TR201103752A2 - Tiyokolşikozit, diklofenak ve lansoprazol kombinasyonları. - Google Patents
Tiyokolşikozit, diklofenak ve lansoprazol kombinasyonları.Info
- Publication number
- TR201103752A2 TR201103752A2 TR2011/03752A TR201103752A TR201103752A2 TR 201103752 A2 TR201103752 A2 TR 201103752A2 TR 2011/03752 A TR2011/03752 A TR 2011/03752A TR 201103752 A TR201103752 A TR 201103752A TR 201103752 A2 TR201103752 A2 TR 201103752A2
- Authority
- TR
- Turkey
- Prior art keywords
- thiocolchicoside
- lansoprazole
- diclofenac
- combinations
- pharmaceutically acceptable
- Prior art date
Links
- LEQAKWQJCITZNK-AXHKHJLKSA-N N-[(7S)-1,2-dimethoxy-10-(methylthio)-9-oxo-3-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide Chemical compound C1([C@@H](NC(C)=O)CCC2=C3)=CC(=O)C(SC)=CC=C1C2=C(OC)C(OC)=C3O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O LEQAKWQJCITZNK-AXHKHJLKSA-N 0.000 title abstract 2
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 title abstract 2
- 229960001259 diclofenac Drugs 0.000 title abstract 2
- MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 title abstract 2
- 229960003174 lansoprazole Drugs 0.000 title abstract 2
- 229960000287 thiocolchicoside Drugs 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 3
- 230000002496 gastric effect Effects 0.000 abstract 1
- 239000003158 myorelaxant agent Substances 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2011/03752A TR201103752A2 (tr) | 2011-04-18 | 2011-04-18 | Tiyokolşikozit, diklofenak ve lansoprazol kombinasyonları. |
| PCT/TR2012/000060 WO2012144964A1 (fr) | 2011-04-18 | 2012-04-18 | Combinaisons de thiocolchicoside, de diclofénac et de lansoprazole |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2011/03752A TR201103752A2 (tr) | 2011-04-18 | 2011-04-18 | Tiyokolşikozit, diklofenak ve lansoprazol kombinasyonları. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201103752A2 true TR201103752A2 (tr) | 2012-11-21 |
Family
ID=46246160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2011/03752A TR201103752A2 (tr) | 2011-04-18 | 2011-04-18 | Tiyokolşikozit, diklofenak ve lansoprazol kombinasyonları. |
Country Status (2)
| Country | Link |
|---|---|
| TR (1) | TR201103752A2 (fr) |
| WO (1) | WO2012144964A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2848260T3 (pl) * | 2013-09-12 | 2016-09-30 | Nowe formulacje tiokolchikozydu | |
| EP2848261B1 (fr) * | 2013-09-12 | 2016-04-20 | Sanovel Ilac Sanayi ve Ticaret A.S. | Formulations pharmaceutiques comprenant un relaxant des muscles et une combinaison d'un analgésique |
| EP2848259B1 (fr) * | 2013-09-12 | 2016-03-23 | Sanovel Ilac Sanayi ve Ticaret A.S. | Formulations pharmaceutiques à libération prolongée de thiocolchicoside |
| EA201692424A1 (ru) * | 2014-06-30 | 2017-04-28 | Сановель Илач Санайи Ве Тиджарет А.Ш. | Комбинации локсопрофена и агониста рецепторов гамма-аминомасляной кислоты |
| WO2016102661A1 (fr) * | 2014-12-23 | 2016-06-30 | Krka, D.D., Novo Mesto | Composition de comprimé pharmaceutique |
| WO2017084680A1 (fr) * | 2015-11-17 | 2017-05-26 | Rontis Hellas S.A. | Composition pharmaceutique contenant un médicament anti-inflammatoire non stéroïdien et un inhibiteur de pompe à protons |
| TR201717134A2 (tr) * | 2016-12-07 | 2018-07-23 | Imuneks Farma Ilac Sanayi Ve Ticaret Anonim Sirketi | Ağrı Ve Enflamasyonun Hızlı Tedavisi İçin Diklofenak Ve H2 Reseptör Antagonistlerinin Çabuk Salımlı Oral Kombinasyonları |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2725134B1 (fr) | 1994-10-04 | 1996-12-20 | Lederle Lab | Nouvelle association pharmaceutique a base d'ibuprofene et de thiocolchicoside |
| FR2735369B1 (fr) | 1995-06-13 | 1997-07-11 | Synthelabo | Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside |
| SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
| WO1998052545A1 (fr) * | 1997-05-22 | 1998-11-26 | The Boots Company Plc | Compositions pharmaceutiques a base de flurbiprofene et d'un agent de masquage de brulure pour le traitement de l'angine |
| US6544556B1 (en) * | 2000-09-11 | 2003-04-08 | Andrx Corporation | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
| AU2002305758B2 (en) | 2001-06-01 | 2006-09-07 | Nuvo Pharmaceuticals (Ireland) Designated Activity Company | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| US20050163847A1 (en) | 2004-01-21 | 2005-07-28 | Andrx Pharmaceuticals, Llc | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug |
| WO2005076987A2 (fr) | 2004-02-10 | 2005-08-25 | Santarus, Inc. | Combinaison d'un inhibiteur de la pompe a protons, d'un tampon et d'un medicament anti-inflammatoire non steroidien |
| US20100297224A1 (en) * | 2006-08-31 | 2010-11-25 | Horizon Therapeutics, Inc. | NSAID Dose Unit Formulations with H2-Receptor Antagonists and Methods of Use |
| TR200703092A1 (tr) | 2007-05-08 | 2008-12-22 | SANOVEL �LA� SAN. VE TiC. A.�. | Flurbiprofen ve kas gevşetici kombinasyonları |
| FR2926723B1 (fr) * | 2008-01-25 | 2010-06-18 | Duo Ge | Associations pharmaceutiques orales. |
| US20090233970A1 (en) | 2008-03-11 | 2009-09-17 | Nickell Robert P | Combined nsaid and acid blocker formulation and method |
| UA102010C2 (ru) | 2009-01-22 | 2013-05-27 | Санофі | Комбинация активных ингредиентов, которая содержит нестероидное противовоспалительное лекарственное средство и производное колхикозида |
-
2011
- 2011-04-18 TR TR2011/03752A patent/TR201103752A2/xx unknown
-
2012
- 2012-04-18 WO PCT/TR2012/000060 patent/WO2012144964A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012144964A1 (fr) | 2012-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120480T1 (el) | Ενωσεις πυραζολοπυριμιδινης | |
| CY1121625T1 (el) | Αναστολεις prmt5 και χρησεις αυτων | |
| CY1119167T1 (el) | Αναστολεις toy nkcc για τη θεραπεια του αυτισμου | |
| TR201103752A2 (tr) | Tiyokolşikozit, diklofenak ve lansoprazol kombinasyonları. | |
| CY1116645T1 (el) | Ενωση-αναστολεας σηματοδοτικου μονοπατιου notch | |
| EA201201263A1 (ru) | Фармацевтическая композиция, содержащая этексилат дабигатрана | |
| EA201390908A1 (ru) | Производные бицикло[3.2.1]октиламида и их применение | |
| BR112012026767A2 (pt) | composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, método para tratar ou previnir distúrbios, e, uso de um composto ou sal | |
| EA201491607A1 (ru) | Модуляторы толлподобных рецепторов | |
| EA201391615A1 (ru) | Дейтерированные потенциаторы cftr | |
| EA201490949A1 (ru) | Ингибиторы киназ | |
| EA201492287A1 (ru) | Дейтерированные производные руксолитиниба | |
| EA201590693A1 (ru) | Ингибиторы gdf-8 | |
| MX375926B (es) | Compuestos y metodos para inhibir el transporte de fosfato. | |
| EA201390804A1 (ru) | Лекарственная форма лакозамида для приема один раз в сутки | |
| CY1124331T1 (el) | Αυξημενη βιοδιαθεσιμοτητα δραστικης ουσιας σε θεραπεια ναλτρεξονης | |
| EA201001710A3 (ru) | Фармацевтическая композиция, которая содержит соль стронция, витамин d и циклодекстрин | |
| BR112013023266A8 (pt) | Inibidores da girase tricíclicos | |
| CY1121999T1 (el) | Φαρμακοτεχνικες μορφες συνδυασμου δαρουναβιρης | |
| EA201490761A1 (ru) | R(+)-n-формилпропаргиламиноиндан | |
| EA201491658A1 (ru) | Таблетки для комбинированной терапии | |
| EA201201202A1 (ru) | Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана | |
| CY1119446T1 (el) | Φαρμακοτεχνικες μορφες δαρουναβιρης | |
| EA201491039A1 (ru) | Комбинации диацереина и нестероидных противовоспалительных лекарственных средств | |
| EA201591175A1 (ru) | Трициклические соединения в качестве ингибиторов cftr |